CTOs on the Move

Deciphera

www.deciphera.com

 
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the effectiveness of many cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known to be directly involved in the growth and spread of many cancers. We use our deep understanding of kinase biology together with a proprietary chemistry library to purposefully design compounds that maintain kinases in a “switched off” or inactivated conformation. Deciphera has developed a diverse pipeline of drug candidates designed to improve outcomes for ...
  • Number of Employees: 100-250
  • Annual Revenue: $500M-1 Billion
  • www.deciphera.com
  • 500 Totten Pond Road 6th Floor
    Waltham, MA USA 02451
  • Phone: 781.209.6400

Executives

Name Title Contact Details
Senthil Gopal
Director of Cyber Security Profile
Elizabeth Ruhl
Senior Director, IT Governance, Risk, and Compliance - Information Security Profile
Stephen Aschettino
Vice President and Chief Information Officer Profile
Stephen Ruddy
Chief Technical Officer Profile

Similar Companies

Attenua

Attenua, Inc. is a pharmaceutical company developing antitussive medications.

Crestwyn Behavioral Health

Crestwyn Behavioral Health, the preferred acute inpatient psychiatric hospital in Memphis, TN, treating mental health disorders in adults & adolescents.

Alnara Pharmaceuticals

Alnara Pharmaceuticals, Inc. is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionical Emas

Bionical Emas is the first and only CRO that combines Clinical Development, Early Access Programs and Clinical Trial Supply. We build close partnerships with our clients, so we can provide you with a unique, integrated service shaped to fit your needs.

Eton Pharmaceuticals

Eton is an innovative pharmaceutical company that searches the world over for meaningful therapies that we can bring to patients living with rare diseases.